These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 35301863)

  • 1. MicroRNAs Regulate TASK-1 and Are Linked to Myocardial Dilatation in Atrial Fibrillation.
    Wiedmann F; Kraft M; Kallenberger S; Büscher A; Paasche A; Blochberger PL; Seeger T; Jávorszky N; Warnecke G; Arif R; Kremer J; Karck M; Frey N; Schmidt C
    J Am Heart Assoc; 2022 Apr; 11(7):e023472. PubMed ID: 35301863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic TWIK-Related Acid-Sensitive K+ Channel (TASK-1) Potassium Channel Inhibitor A293 Facilitates Acute Cardioversion of Paroxysmal Atrial Fibrillation in a Porcine Large Animal Model.
    Wiedmann F; Beyersdorf C; Zhou X; Büscher A; Kraft M; Nietfeld J; Walz TP; Unger LA; Loewe A; Schmack B; Ruhparwar A; Karck M; Thomas D; Borggrefe M; Seemann G; Katus HA; Schmidt C
    J Am Heart Assoc; 2020 May; 9(10):e015751. PubMed ID: 32390491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic Ablation of TASK-1 (Tandem of P Domains in a Weak Inward Rectifying K
    Schmidt C; Wiedmann F; Beyersdorf C; Zhao Z; El-Battrawy I; Lan H; Szabo G; Li X; Lang S; Korkmaz-Icöz S; Rapti K; Jungmann A; Ratte A; Müller OJ; Karck M; Seemann G; Akin I; Borggrefe M; Zhou XB; Katus HA; Thomas D
    Circ Arrhythm Electrophysiol; 2019 Sep; 12(9):e007465. PubMed ID: 31514528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variation in the two-pore domain potassium channel, TASK-1, may contribute to an atrial substrate for arrhythmogenesis.
    Liang B; Soka M; Christensen AH; Olesen MS; Larsen AP; Knop FK; Wang F; Nielsen JB; Andersen MN; Humphreys D; Mann SA; Huttner IG; Vandenberg JI; Svendsen JH; Haunsø S; Preiss T; Seebohm G; Olesen SP; Schmitt N; Fatkin D
    J Mol Cell Cardiol; 2014 Feb; 67():69-76. PubMed ID: 24374141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrial fibrillation and heart failure-associated remodeling of two-pore-domain potassium (K
    Wiedmann F; Schulte JS; Gomes B; Zafeiriou MP; Ratte A; Rathjens F; Fehrmann E; Scholz B; Voigt N; Müller FU; Thomas D; Katus HA; Schmidt C
    Basic Res Cardiol; 2018 Jun; 113(4):27. PubMed ID: 29881975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TASK-1 current is inhibited by phosphorylation during human and canine chronic atrial fibrillation.
    Harleton E; Besana A; Chandra P; Danilo P; Rosen TS; Rosen MR; Argenziano M; Robinson RB; Feinmark SJ
    Am J Physiol Heart Circ Physiol; 2015 Jan; 308(2):H126-34. PubMed ID: 25437921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac expression and atrial fibrillation-associated remodeling of K₂p2.1 (TREK-1) K⁺ channels in a porcine model.
    Schmidt C; Wiedmann F; Tristram F; Anand P; Wenzel W; Lugenbiel P; Schweizer PA; Katus HA; Thomas D
    Life Sci; 2014 Mar; 97(2):107-15. PubMed ID: 24345461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in microRNA-1 expression and IK1 up-regulation in human atrial fibrillation.
    Girmatsion Z; Biliczki P; Bonauer A; Wimmer-Greinecker G; Scherer M; Moritz A; Bukowska A; Goette A; Nattel S; Hohnloser SH; Ehrlich JR
    Heart Rhythm; 2009 Dec; 6(12):1802-9. PubMed ID: 19959133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of K(2P)3.1 K+ Current Causes Action Potential Shortening in Patients With Chronic Atrial Fibrillation.
    Schmidt C; Wiedmann F; Voigt N; Zhou XB; Heijman J; Lang S; Albert V; Kallenberger S; Ruhparwar A; Szabó G; Kallenbach K; Karck M; Borggrefe M; Biliczki P; Ehrlich JR; Baczkó I; Lugenbiel P; Schweizer PA; Donner BC; Katus HA; Dobrev D; Thomas D
    Circulation; 2015 Jul; 132(2):82-92. PubMed ID: 25951834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. pH-dependent inhibition of K₂P3.1 prolongs atrial refractoriness in whole hearts.
    Skarsfeldt MA; Jepps TA; Bomholtz SH; Abildgaard L; Sørensen US; Gregers E; Svendsen JH; Diness JG; Grunnet M; Schmitt N; Olesen SP; Bentzen BH
    Pflugers Arch; 2016 Apr; 468(4):643-54. PubMed ID: 26729267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inverse remodelling of K2P3.1 K+ channel expression and action potential duration in left ventricular dysfunction and atrial fibrillation: implications for patient-specific antiarrhythmic drug therapy.
    Schmidt C; Wiedmann F; Zhou XB; Heijman J; Voigt N; Ratte A; Lang S; Kallenberger SM; Campana C; Weymann A; De Simone R; Szabo G; Ruhparwar A; Kallenbach K; Karck M; Ehrlich JR; Baczkó I; Borggrefe M; Ravens U; Dobrev D; Katus HA; Thomas D
    Eur Heart J; 2017 Jun; 38(22):1764-1774. PubMed ID: 28057773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of atrial fibrillation-associated microRNAs in left and right atria of rheumatic mitral valve disease patients.
    Yan Y; Shi R; Yu X; Sun C; Zang W; Tian H
    Genes Genet Syst; 2019 Apr; 94(1):23-34. PubMed ID: 30584185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in potassium channel gene expression in atria of patients with persistent and paroxysmal atrial fibrillation: differential regulation of protein and mRNA levels for K+ channels.
    Brundel BJ; Van Gelder IC; Henning RH; Tuinenburg AE; Wietses M; Grandjean JG; Wilde AA; Van Gilst WH; Crijns HJ
    J Am Coll Cardiol; 2001 Mar; 37(3):926-32. PubMed ID: 11693772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrial Fibrillation-Mediated Upregulation of miR-30d Regulates Myocardial Electrical Remodeling of the G-Protein-Gated K(+) Channel, IK.ACh.
    Morishima M; Iwata E; Nakada C; Tsukamoto Y; Takanari H; Miyamoto S; Moriyama M; Ono K
    Circ J; 2016 May; 80(6):1346-55. PubMed ID: 27180889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treating atrial fibrillation with radiofrequency ablation to reverse changes in microRNAs regulating the ion-channel proteins.
    Yue YN; Li B; Xu GY; Yang SX
    Bratisl Lek Listy; 2021; 122(6):396-404. PubMed ID: 34002613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of the SK3 channel by microRNA-499--potential role in atrial fibrillation.
    Ling TY; Wang XL; Chai Q; Lau TW; Koestler CM; Park SJ; Daly RC; Greason KL; Jen J; Wu LQ; Shen WF; Shen WK; Cha YM; Lee HC
    Heart Rhythm; 2013 Jul; 10(7):1001-9. PubMed ID: 23499625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of atrial fibrillation with doxapram: TASK-1 potassium channel inhibition as a novel pharmacological strategy.
    Wiedmann F; Beyersdorf C; Zhou XB; Kraft M; Paasche A; Jávorszky N; Rinné S; Sutanto H; Büscher A; Foerster KI; Blank A; El-Battrawy I; Li X; Lang S; Tochtermann U; Kremer J; Arif R; Karck M; Decher N; van Loon G; Akin I; Borggrefe M; Kallenberger S; Heijman J; Haefeli WE; Katus HA; Schmidt C
    Cardiovasc Res; 2022 Jun; 118(7):1728-1741. PubMed ID: 34028533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning, functional characterization, and remodeling of K2P3.1 (TASK-1) potassium channels in a porcine model of atrial fibrillation and heart failure.
    Schmidt C; Wiedmann F; Langer C; Tristram F; Anand P; Wenzel W; Lugenbiel P; Schweizer PA; Katus HA; Thomas D
    Heart Rhythm; 2014 Oct; 11(10):1798-805. PubMed ID: 24952150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-21 via Dysregulation of WW Domain-Containing Protein 1 Regulate Atrial Fibrosis in Atrial Fibrillation.
    Tao H; Zhang M; Yang JJ; Shi KH
    Heart Lung Circ; 2018 Jan; 27(1):104-113. PubMed ID: 28495464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human atrial ion channel and transporter subunit gene-expression remodeling associated with valvular heart disease and atrial fibrillation.
    Gaborit N; Steenman M; Lamirault G; Le Meur N; Le Bouter S; Lande G; Léger J; Charpentier F; Christ T; Dobrev D; Escande D; Nattel S; Demolombe S
    Circulation; 2005 Jul; 112(4):471-81. PubMed ID: 16027256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.